(CIDRAP News) – A government advisory committee yesterday endorsed the safety and immunogenicity of an adjuvant-containing H5N1 influenza vaccine proposed for inclusion in the US pandemic emergency stockpile, signaling that it could become the first adjuvanted flu vaccine to win approval in the United States.
(CIDRAP News) The first wave of H1N1 vaccine will probably consist of 3.4 million doses of MedImmune's nasal-spray product and is likely to reach providers the first week in October, federal health officials said today.
(CIDRAP News) On the second and final day of an Institute of Medicine (IOM) task force meeting on how to protect healthcare workers from the novel H1N1 virus, experts focused on issues surrounding the effectiveness and practical use of masks and respirators in work settings.
The IOM task force's goal is to make recommendations about how to protect healthcare workers during the H1N1 pandemic.
Twenty countries were reporting a total of 985 confirmed cases of influenza A/H1N1 (swine flu) as of early today, the World Health Organization (WHO) reported. Mexico has reported 590 cases with 25 deaths. The WHO total includes yesterday's US report of 226 cases in 30 states, with one death. Other countries with more than 10 cases were Canada, 85; Spain, 40; and the United Kingdom, 15. [WHO statement]